{"filing":{"accession_number":"0001554855-26-001389","cik":"0000888721","ticker":"TRIB","company_name":"TRINITY BIOTECH PLC","form":"6-K","filing_date":"2026-06-23","report_date":null,"primary_document":"MainDocument.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/888721/000155485526001389/MainDocument.htm"},"events":[{"id":12991,"run_id":11533,"accession_number":"0001554855-26-001389","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"Trinity Biotech announced the launch of Trinovium, a new subsidiary focused on advanced liquid cooling solutions for AI data centers. This represents a material strategic expansion into a new market segment (projected to grow from $4 billion in 2026 to $27 billion by 2033) leveraging existing manufacturing capacity. While not a traditional M\u0026A transaction, the creation of a dedicated subsidiary with a distinct business focus and capital-efficient entry into a high-growth market constitutes a significant operational and strategic initiative that would affect a reasonable investor's assessment of the company's growth prospects and business diversification.","company_name":"TRINITY BIOTECH PLC","ticker":"TRIB","filing_date":"2026-06-23","form":"6-K","submitted_at":null,"items":[{"id":10005,"accession_number":"0001554855-26-001389","item_number":"EX-99.1","item_title":"ex991_1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Trinity Biotech announced the launch of Trinovium, a new subsidiary focused on advanced liquid cooling solutions for AI data centers. This represents a material strategic expansion into a new market segment (projected to grow from $4 billion in 2026 to $27 billion by 2033) leveraging existing manufacturing capacity. While not a traditional M\u0026A transaction, the creation of a dedicated subsidiary with a distinct business focus and capital-efficient entry into a high-growth market constitutes a significant operational and strategic initiative that would affect a reasonable investor's assessment of the company's growth prospects and business diversification.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-23T11:40:37.857465+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10005,"accession_number":"0001554855-26-001389","item_number":"EX-99.1","item_title":"ex991_1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Trinity Biotech announced the launch of Trinovium, a new subsidiary focused on advanced liquid cooling solutions for AI data centers. This represents a material strategic expansion into a new market segment (projected to grow from $4 billion in 2026 to $27 billion by 2033) leveraging existing manufacturing capacity. While not a traditional M\u0026A transaction, the creation of a dedicated subsidiary with a distinct business focus and capital-efficient entry into a high-growth market constitutes a significant operational and strategic initiative that would affect a reasonable investor's assessment of the company's growth prospects and business diversification.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-23T11:40:37.857465+00:00","company_name":"TRINITY BIOTECH PLC","ticker":"TRIB","filing_date":"2026-06-23"}]}